In a c-MYC-overexpressing/p53 knockout mouse model of HCC, pCAR-Ms presented tumor antigens and reshaped the tumor microenvironment by activating T cells, thereby promoting an anti-tumor immune response. This evidence concerns the gene TP53 and neoplasm.